Armatus Bio
PrivateLast Round
Grant
May 19, 2025
Total Funding Raised
$250,000
Company Overview
Armatus Bio operates in Healthcare & Life Sciences and is based in Columbus, Ohio. Its latest recorded funding round was a Grant round in May 2025.
Armatus Bio is a biotechnology company developing vectorized RNAi therapeutics to treat genetic neurological and neuromuscular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Armatus Bio Comparables
Compare Armatus Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shift Pharmaceuticals | 83% | |
| Facio BioTherapies | 82% | |
| MAAsiRNA | 81% |
For institutional investors. Book with your work email.
Armatus Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 19, 2025 | ||||
| VC Round | May 6, 2025 | ||||
| Seed | Nov 16, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Armatus Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JumpStart Ventures | Seed |
| CincyTech | Seed |
| Solve FSHD | VC Round |
| Rev1 Ventures | Seed |
| Angel Physicians Fund | Seed |
| CMT Research Foundation | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2025
$250K grant round completed.
- Nov 16, 2023
Seed round raised with support from Charcot-Marie-Tooth Association and CMT Research Foundation.
For institutional investors. Book with your work email.
Armatus Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Armatus Bio's valuation, stock price, and market status.
Is Armatus Bio a public or private company?
Armatus Bio is a private company.
What is the current stock price of Armatus Bio?
Armatus Bio is a private company, so its shares have no public market price. Caplight tracks Armatus Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Armatus Bio worth (valuation)?
Valuation information for Armatus Bio is not publicly available.
Can I buy Armatus Bio stock?
Armatus Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Armatus Bio's last funding round?
Armatus Bio's most recent funding round was Grant on May 19, 2025.
Who are the main investors in Armatus Bio?
Key investors in Armatus Bio include Solve FSHD.
Will Armatus Bio IPO soon?
No public IPO plans have been announced for Armatus Bio.
How can I track Armatus Bio secondary market activity?
Caplight tracks bids, offers, and trades in Armatus Bio's shares on secondary markets.